126 results
Page 5 of 7
6-K
EX-99.1
ibvjxvao
31 Oct 13
Teva Reports Third Quarter 2013 Results
12:00am
6-K
a8ch4mit7wmr7zg2 df6
31 Oct 13
Current report (foreign)
12:00am
6-K
EX-99.1
q09 sup2u0w
30 Oct 13
Teva Announces Departure of President and Ceo
12:00am
6-K
EX-99.1
1xeanop4sdfxo38q
10 Oct 13
Live Filing
12:00am
6-K
EX-99.1
ep4ctpab pnnty13uy
9 Oct 13
Teva R&D in Focus - Respiratory Webinar for the investment communityOctober 8th, 2013
12:00am
6-K
EX-99.1
ksnfib5
4 Oct 13
Live Filing
12:00am
6-K
EX-99.1
fn64odx 0aj1le
3 Oct 13
Teva Announces Favorable Ruling on Copaxone Patent Litigation In the Netherlands
12:00am
6-K
EX-99.1
7yx0n64m51
3 Oct 13
Teva to Present Further Results of Twenty-year Open-label Extension Study of Glatiramer Acetate 20 MG Daily for Relapsing-remitting Multiple Sclerosis
12:00am
6-K
EX-99.1
xdfpv1 tb1sy8d9zu2d
1 Oct 13
Teva Announces Launch of Generic Zemplar® In the United States
12:00am
6-K
EX-99.1
j9cf51cbvau39
1 Oct 13
Live Filing
12:00am
6-K
EX-99.1
w3gk5q8oudcssylkxzm
30 Sep 13
Live Filing
12:00am
6-K
EX-99.1
0polw9
26 Sep 13
Live Filing
12:00am
6-K
EX-99.1
a8jdso0voy3x
24 Sep 13
Teva Announces Exclusive Launch of Generic Adenoscan® In the United States
12:00am
6-K
EX-99.1
8w9gntd5 xu0pklnn
23 Sep 13
Teva Announces Favorable Court Ruling In Azilect® Patent Infringement Litigation Against Mylan
12:00am
6-K
EX-99.1
yhj5zwld0mbn92
20 Sep 13
Teva Announces Exclusive Launch of Generic Niaspan® In the United States
12:00am
6-K
EX-99.1
hifaerqu dyw83
17 Sep 13
Fda Approves Teva’s Treanda® (Bendamustine Hci) Injection, a New Liquid Formulation
12:00am
6-K
EX-99.1
hsqbxkc ji65lwxsef
30 Aug 13
Live Filing
12:00am
6-K
EX-99
jtm7x jvh6url
12 Aug 13
Teva Pharmaceuticals and Perrigo Company Announce the U.s. Launch of Generic Temozolomide
12:00am
6-K
EX-99.1
ary3rutx4im sx8l4m
8 Aug 13
Live Filing
12:00am
6-K
EX-99.1
5op rsdqfqbh3
1 Aug 13
Teva Reports Second Quarter 2013 Results
12:00am